Pharm-Rx Carvedilol (Route-Ii)

Product families

Other characteristics

Markets

Healthcare & Pharma

Defination

Carvedilol contains NLT 98.0% and NMT 102.0% of C₂₄H₂₆N₂O₄ , calculated on the dried basis.

Technology

Pharmaceuticals & Nutraceuticals

FDA Disclaimer

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Storage Information

Preserve in tight containers, and store at controlled room temperature.

USP Reference Standards

USP Carvedilol RS; USP Carvedilol Related Compound A RS; 1-(4-(2-Hydroxy-3-(2-(2-methoxy phenoxy)ethylamino) propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy) ethylamino) propan-2-ol.; C₃₆H₄₃N₃O₇ 629.75; USP Carvedilol Related Compound B RS; 3,3'-(2-(2-Methoxyphenoxy)ethylazanediyl)bis(1-(9Hcarbazol-4-yloxy)propan-2-ol).; C₃₉H₃₉N₃O₆ ▲645.76▲ (ERR 1-Jan-2021); USP Carvedilol Related Compound C RS; 1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol.; C₃₁H₃₂N₂O₄ ▲496.61▲ (ERR 1-Jan-2021); USP Carvedilol Related Compound D RS; 4-(Oxiran-2-ylmethoxy)-9H-carbazole.; C₁₅H₁₃NO₂ 239.27; USP Carvedilol Related Compound E RS; ▲[NOTE—This material may be available in the free base; or salt form.]▲; 2-(2-Methoxyphenoxy)ethyl amine.; C₉H₁₃NO₂ 167.21; 2-(2-Methoxyphenoxy)ethyl amine hydrochloride monohydrate; C₉H₁₃NO₂ · HCl · H2O 221.68▲ (ERR 1-Jan-2021); USP Carvedilol System Suitability Mixture RS ▲Contains a mixture of carvedilol related compound F in a matrix of carvedilol drug substance; Carvedilol. Carvedilol related compound F. [NOTE—This material may be available in the free base or salt form.]; 1-(2-(2-Methoxyphenoxy)ethylamino)-3-(2,3,4,9- tetrahydro-1H-carbazol-5-yloxy)propan-2-ol. C₂₄H₃₀N₂O₄ 410.51; 1-(2-(2-Methoxyphenoxy)ethylamino)-3-(2,3,4,9- tetrahydro-1H-carbazol-5-yloxy)propan-2-ol acetate. C₂₄H₃₀N₂O₄ · C₂H₄O₂ 470.57▲ (ERR 1-Jan-2021)

Show in full